Gary Palgon, CISSP’s Post

Can't wait for Asembia's AXS24 Summit so we can discuss the challenges with commercializing specialty therapies and how IntegriChain uniquely helps #pharmaceutical manufacturers balance patient access with net-price realization.

Access to Limited Distribution Drugs (LDD) are important for specialty pharmacies to provide comprehensive, patient-centered care. LDDs are medications where manufacturers restrict access to a small number of specialty pharmacies. Come join my colleagues and me in discussions around this important topic!

Now available in the October issue of Radar on Specialty Pharmacy: The latest on PBM private-label units, how flexible CAR-T monitoring could help with post-treatment barriers, employers aren't happy with PBM's specialty pharmacy services, and more top stories. https://hubs.ly/Q02S-Wkf0

Join me today for the "Stewardship of 340B Savings" Breakout Session and hear how marketplace factors are impacting total savings. #340B

We just ran across an interesting article that spotlights four key takeaways from the Asembia Specialty Pharmacy Summit, which was held earlier this year. The article is from the perspective of four lawyers who attended the Summit. Their perspectives and conclusions merit consideration by all specialty pharmacies in their strategic planning, as they are perhaps better positioned to see the forest as well as all the trees. #specialtypharmacy #marketaccess

In Pharmacy Times, my colleague Dinesh Kabaleeswaran explains how #pharma can use integrated lab, claims and market access data to refine patient targeting, eliminate access barriers and optimize reimbursement - Claims, Lab, and EHR Data Can Make or Break a Drug Launch (pharmacytimes.com)

It’s not too late to sign up if you haven’t already! Sign up now for top tips on how to maximise Pharmacy First in your pharmacy!

Are you going to Asembia? Book some time with D2 to learn how you can steamline the Prior Authorization process and enhance patient communication via digital technologies.

We have been ideating about this newsletter for what feels like forever! So proud of our team for getting it across the finish line! You, too, can subscribe to the Prime Post Newsletter and receive valuable content about how Prime reimagines pharmacy management! 📰 #PrimeTherapeutics #PrimePostNewsletter

We just ran across an interesting article that spotlights four key takeaways from the Asembia Specialty Pharmacy Summit, which was held earlier this year. The article is from the perspective of four lawyers who attended the Summit. Their perspectives and conclusions merit consideration by all specialty pharmacies in their strategic planning, as they are perhaps better positioned to see the forest as well as all the trees. #specialtypharmacy #marketaccess